PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33548287-0	2021	BBG enhances OLT1177-induced NLRP3 inflammasome inactivation by targeting P2X7R/NLRP3 and MyD88/NF-kappaB signaling in DSS-induced colitis in rats.	coomassie Brilliant Blue	0-3	NLR family, pyrin domain containing 3	Rattus norvegicus	29-34	
33548287-10	2021	However, the combined administration of OLT1177 with BBG potentiated its inhibitory effect on the NLRP3, which was reflected by the additional suppressive effect on caspase-1, IL-1beta, IL-18 levels.	coomassie Brilliant Blue	53-56	NLR family, pyrin domain containing 3	Rattus norvegicus	98-103	
33548287-0	2021	BBG enhances OLT1177-induced NLRP3 inflammasome inactivation by targeting P2X7R/NLRP3 and MyD88/NF-kappaB signaling in DSS-induced colitis in rats.	coomassie Brilliant Blue	0-3	NLR family, pyrin domain containing 3	Rattus norvegicus	80-85	
33548287-9	2021	Individual BBG or OLT1177 administration decreased NLRP3 inflammasome recruitment and subsequent activation of caspase-1, IL-1beta, and IL-18.	coomassie Brilliant Blue	11-14	NLR family, pyrin domain containing 3	Rattus norvegicus	51-56	
32516946-7	2020	Increased IL-2, IL-6, TNFalpha, IL-1beta, IL-18 and overexpression of NLRP3 inflammasome were induced by angiotensin II and suppressed by BBG.	coomassie Brilliant Blue	138-141	NLR family, pyrin domain containing 3	Rattus norvegicus	70-75	
34321905-0	2021	The Supportive Role of NSC328382, a P2X7R Antagonist, in Enhancing the Inhibitory Effect of CRID3 on NLRP3 Inflammasome Activation in Rats with Dextran Sodium Sulfate-Induced Colitis.	coomassie Brilliant Blue	23-32	NLR family, pyrin domain containing 3	Rattus norvegicus	101-106	
34208781-9	2021	Additionally, BBG prevents NLRP3 inflammasome activation and consequently the release of active interleukin (IL)-1 and IL-18, involved in the activation of nociceptors.	coomassie Brilliant Blue	14-17	NLR family, pyrin domain containing 3	Rattus norvegicus	27-32	
35202914-4	2022	Coomassie brilliant blue G-250 (CBBG) is proved to be a safe highly selective P2x7R antagonist with promising consequent inactivation of NLRP3 inflammasome.	coomassie Brilliant Blue	32-36	NLR family, pyrin domain containing 3	Rattus norvegicus	137-142	
35202914-10	2022	The lung protective effects of CBBG might be attributed on the one hand to the inhibition of NLRP3 inflammasome and on the other hand to the inactivation of NF-kappaB.	coomassie Brilliant Blue	31-35	NLR family, pyrin domain containing 3	Rattus norvegicus	93-98